Key Details
Price
$227.65PE Ratio
38.85Annual ROE
11.26%Beta
1.40Events Calendar
Next earnings date:
Apr 30, 2025Recent quarterly earnings:
Feb 5, 2025Recent annual earnings:
Feb 5, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Align Technology (ALGN 0.75%), famous for its Invisalign clear aligners and digital dental solutions, shared its fourth-quarter 2024 results on February 5, 2025. The earnings report showed consistent performance despite challenges with currency and demand.
While the revenue and earnings per share (EPS) for Align Technology (ALGN) provide insight into its performance for the quarter ending December 2024, it could be helpful to look at how these important figures stack up against Wall Street predictions and last year's results.
Here's a quick look at how five MedTech stocks—BSX, HOLX, TECH, STE, and ALGN—are predicted to perform in their quarterly reports, which will be announced tomorrow.
Look for companies that have reliable business models, effective management, and the ability to grow their market share over time in big industries. Notable investments include M&T Bank, Ashtead Group, Installed Building Products, Fiserv, Ferguson, Kinsale Capital Group, Align Technologies, and Medpace Holdings. The focus is on careful financial management, strong market presence, and smart use of capital to enhance future growth and benefit shareholders.
Align Technology (ALGN) has a strong track record of surprising with its earnings and currently has the right factors in place that suggest it may exceed expectations in its upcoming quarterly report.
ALGN is experiencing a drop in the average selling prices (ASPs) of Invisalign for complete treatment options. This has led to a decrease in the company's overall revenue.
Align Technology and Coca-Cola are included in the Zacks Investment Ideas article.
In January, consider buying two stocks, ALGN and KO, as they are priced at least 20% lower than their average Zacks price targets and provide excellent long-term value.
Leerink Partners has raised its rating for Align Technology Inc (ALGN), highlighting potential growth opportunities until 2025 due to the possibility of increased profit margins.
Align Technology's stock has struggled over the last year because of weak consumer interest in its clear aligner products. However, I anticipate that growth will pick up to at least 5% in FY25, largely due to high demand for the systems and services offered to doctors. Additionally, profit margins are likely to increase after the restructuring plan that started in Q4.
FAQ
- What is the ticker symbol for Align Technology?
- Does Align Technology pay dividends?
- What sector is Align Technology in?
- What industry is Align Technology in?
- What country is Align Technology based in?
- When did Align Technology go public?
- Is Align Technology in the S&P 500?
- Is Align Technology in the NASDAQ 100?
- Is Align Technology in the Dow Jones?
- When was Align Technology's last earnings report?
- When does Align Technology report earnings?
- Should I buy Align Technology stock now?